Valuation (34%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -53.83 | 32.81 |
PEG Ratio (TTM) | 0.31 | 9.13 |
P/S Ratio (TTM) | 1.23 | 4.49 |
P/B Ratio (TTM) | 0.74 | 9.77 |
P/FCF Ratio (TTM) | -16.02 | 31.70 |
Price to 5YR AVG Earnings Ratio | -8.84 | 68.37 |
Price to 5YR AVG FCF Ratio | -15.68 | 55.57 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -1.20% | 6.94% |
ROE (TTM) | -1.37% | 29.10% |
Net Profit Margin (TTM) | -2.29% | 5.14% |
ROIC 5YR AVG | -17.70% | 5.64% |
Growth (5%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -49.10% | -8,806.24% | -5,833.94% |
Revenue | 2.78% | -21.50% | -10.59% |
Net Income | -49.03% | -9,264.17% | -6,113.91% |
Cash Flow | -90.85% | -6.85% | -109.53% |
Health (33%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 5.82 | 2.34 |
Quick Ratio (TTM) | 5.73 | 1.78 |
D/E Ratio (TTM) | N/A | 1.13 |
Interest Coverage (TTM) | -564.50 | 8.28 |
Piotroski F-Score | 2 | 6 |
Altman Z-Score | 0.91 | 5.18 |
LTL to 5YR AVG FCF | -0.26 | 5.51 |
Shares Outstanding Growth 5YR AVG | 4.92% | 11.02% |